Mosaic chromosomal alterations in peripheral blood leukocytes of children in sub-Saharan Africa.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
06 Dec 2023
Historique:
received: 09 02 2023
accepted: 22 11 2023
medline: 11 12 2023
pubmed: 7 12 2023
entrez: 6 12 2023
Statut: epublish

Résumé

In high-income countries, mosaic chromosomal alterations in peripheral blood leukocytes are associated with an elevated risk of adverse health outcomes, including hematologic malignancies. We investigate mosaic chromosomal alterations in sub-Saharan Africa among 931 children with Burkitt lymphoma, an aggressive lymphoma commonly characterized by immunoglobulin-MYC chromosomal rearrangements, 3822 Burkitt lymphoma-free children, and 674 cancer-free men from Ghana. We find autosomal and X chromosome mosaic chromosomal alterations in 3.4% and 1.7% of Burkitt lymphoma-free children, and 8.4% and 3.7% of children with Burkitt lymphoma (P-values = 5.7×10

Identifiants

pubmed: 38057307
doi: 10.1038/s41467-023-43881-0
pii: 10.1038/s41467-023-43881-0
pmc: PMC10700489
doi:

Substances chimiques

Immunoglobulins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8081

Subventions

Organisme : NHLBI NIH HHS
ID : HHSN261201100007C
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261201100007I
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261201100063C
Pays : United States

Informations de copyright

© 2023. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.

Références

Leukemia. 2021 Apr;35(4):1209-1213
pubmed: 33051549
Hum Mutat. 2022 Dec;43(12):1979-1993
pubmed: 36054329
Blood. 2018 Feb 1;131(5):496-504
pubmed: 29141946
Am J Hum Genet. 2015 Mar 5;96(3):487-97
pubmed: 25748358
Nat Commun. 2019 Mar 29;10(1):1459
pubmed: 30926794
Am J Med. 1989 Aug;87(2):139-43
pubmed: 2667356
Nature. 2017 Oct 11;550(7675):244-248
pubmed: 29022598
Blood. 2006 Apr 1;107(7):2928-35
pubmed: 16332968
Nat Genet. 2012 May 06;44(6):642-50
pubmed: 22561516
Leukemia. 2022 Jul;36(7):1720-1748
pubmed: 35732829
Cell Death Dis. 2022 Oct 22;13(10):892
pubmed: 36270981
J Infect Dis. 2006 Feb 1;193(3):422-6
pubmed: 16388490
Sci Rep. 2021 Jan 13;11(1):1193
pubmed: 33441948
Genome Med. 2019 Apr 30;11(1):27
pubmed: 31039827
Science. 2015 Jun 5;348(6239):aaa0698
pubmed: 26045439
Bioinformatics. 2014 May 15;30(10):1363-9
pubmed: 24478339
Eur J Cancer (1965). 1981 May;17(5):577-84
pubmed: 6271555
Nat Genet. 2012 Dec;44(12):1316-20
pubmed: 23143595
Hum Mol Genet. 2015 May 15;24(10):2733-45
pubmed: 25634561
Am J Hum Genet. 2010 Jul 9;87(1):129-38
pubmed: 20598279
Matern Child Health J. 2015 Mar;19(3):606-14
pubmed: 24951129
Nat Rev Genet. 2002 Oct;3(10):748-58
pubmed: 12360233
Lancet. 1964 Mar 28;1(7335):702-3
pubmed: 14107961
Blood. 2002 Apr 15;99(8):2662-9
pubmed: 11929751
Semin Hematol. 2013 Oct;50(4):348-59
pubmed: 24246702
Nat Rev Immunol. 2015 Mar;15(3):172-84
pubmed: 25712152
Nat Genet. 2012 Dec;44(12):1321-5
pubmed: 23143597
Haematologica. 2010 Dec;95(12):2047-55
pubmed: 20823134
Nat Rev Dis Primers. 2022 Dec 15;8(1):78
pubmed: 36522349
Proc Natl Acad Sci U S A. 2023 Jan 10;120(2):e2211055120
pubmed: 36595676
Nat Genet. 2015 Nov;47(11):1316-1325
pubmed: 26437030
Leukemia. 2021 Jul;35(7):2002-2016
pubmed: 33953289
Nat Med. 2021 Jun;27(6):1012-1024
pubmed: 34099924
Blood. 2023 Feb 23;141(8):904-916
pubmed: 36201743
Ann Hematol. 2002 Aug;81(8):441-7
pubmed: 12224001
Nature. 2022 Jul;607(7918):366-373
pubmed: 35705809
Br J Haematol. 2008 Mar;140(5):516-26
pubmed: 18275429
Int J Cancer. 2020 Feb 15;146(4):953-969
pubmed: 31054214
J Mol Diagn. 2006 May;8(2):141-51
pubmed: 16645199
Cancer Res. 2019 Jun 15;79(12):3125-3138
pubmed: 31000522
PLoS Genet. 2019 Mar 8;15(3):e1008027
pubmed: 30849090
Sci Rep. 2014 Jan 17;4:3741
pubmed: 24434689
Nature. 2012 Oct 4;490(7418):116-20
pubmed: 22885699
Nat Genet. 2009 May;41(5):521-3
pubmed: 19330029
Nat Biotechnol. 2015 Mar;33(3):290-5
pubmed: 25690850
Infect Agent Cancer. 2021 Jun 7;16(1):40
pubmed: 34099001
PLoS Pathog. 2015 Oct 15;11(10):e1005158
pubmed: 26468873
Br J Haematol. 2018 Jun;181(5):604-613
pubmed: 29687880
Mol Cancer Res. 2017 May;15(5):563-576
pubmed: 28465297
J Urol. 2014 Sep;192(3):730-5
pubmed: 24747091
J Genet Genomics. 2017 Feb 20;44(2):119-121
pubmed: 28162959
N Engl J Med. 2006 Jun 8;354(23):2419-30
pubmed: 16760442
Int J Cancer. 1985 Apr 15;35(4):435-41
pubmed: 2985508
Nat Genet. 2016 May;48(5):563-8
pubmed: 27064253
Blood. 2019 Mar 21;133(12):1313-1324
pubmed: 30617194
J Infect Dis. 2016 Mar 15;213(6):985-91
pubmed: 26531246
Nat Commun. 2016 Jun 13;7:11843
pubmed: 27291797
BMC Cancer. 2014 Dec 13;14:944
pubmed: 25495526
Nat Genet. 2012 May 06;44(6):651-8
pubmed: 22561519
Cell. 1999 Jan 8;96(1):35-45
pubmed: 9989495
Cancers (Basel). 2022 Jun 04;14(11):
pubmed: 35681780
RNA. 2021 Dec;27(12):1577-1588
pubmed: 34535544
Nature. 2018 Jul;559(7714):350-355
pubmed: 29995854
Cell Genom. 2023 May 02;3(6):100305
pubmed: 37388907
J Natl Cancer Inst. 1969 Jan;42(1):19-28
pubmed: 4303830
Nat Rev Genet. 2021 Aug;22(8):502-517
pubmed: 33833443

Auteurs

Weiyin Zhou (W)

Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD, USA.
Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.

Anja Fischer (A)

Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.

Martin D Ogwang (MD)

EMBLEM Study, St. Mary's Hospital, Lacor, Gulu, Uganda.

Wen Luo (W)

Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD, USA.
Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.

Patrick Kerchan (P)

EMBLEM Study, Kuluva Hospital, Arua, Uganda.

Steven J Reynolds (SJ)

Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Constance N Tenge (CN)

EMBLEM Study, Moi University College of Health Sciences, Eldoret, Kenya.

Pamela A Were (PA)

EMBLEM Study, Academic Model Providing Access To Healthcare (AMPATH), Eldoret, Kenya.

Robert T Kuremu (RT)

EMBLEM Study, Moi University College of Health Sciences, Eldoret, Kenya.

Walter N Wekesa (WN)

EMBLEM Study, Moi University College of Health Sciences, Eldoret, Kenya.

Nestory Masalu (N)

EMBLEM Study, Bugando Medical Center, Mwanza, Tanzania.

Esther Kawira (E)

EMBLEM Study, Shirati Health, Education, and Development Foundation, Shirati, Tanzania.

Tobias Kinyera (T)

EMBLEM Study, St. Mary's Hospital, Lacor, Gulu, Uganda.
EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.

Isaac Otim (I)

EMBLEM Study, St. Mary's Hospital, Lacor, Gulu, Uganda.
EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.

Ismail D Legason (ID)

EMBLEM Study, Kuluva Hospital, Arua, Uganda.
EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.

Hadijah Nabalende (H)

EMBLEM Study, St. Mary's Hospital, Lacor, Gulu, Uganda.
EMBLEM Study, African Field Epidemiology Network, Kampala, Uganda.

Leona W Ayers (LW)

Department of Pathology, The Ohio State University, Columbus, OH, USA.

Kishor Bhatia (K)

Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD, USA.

James J Goedert (JJ)

Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD, USA.

Mateus H Gouveia (MH)

Center for Research on Genomics & Global Health, NHGRI, National Institutes of Health, Bethesda, MD, USA.

Nathan Cole (N)

Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD, USA.
Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.

Belynda Hicks (B)

Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD, USA.
Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.

Kristine Jones (K)

Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD, USA.
Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.

Michael Hummel (M)

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Berlin, Germany.
Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, D-10117, Berlin, Germany.

Mathias Schlesner (M)

Biomedical Informatics, Data Mining and Data Analytics, University of Augsburg, Augsburg, Germany.

George Chagaluka (G)

Departments of Pediatrics and Surgery, College of Medicine, University of Malawi, Blantyre, Malawi.

Nora Mutalima (N)

Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, UK.
Cancer Epidemiology Unit, University of Oxford, Oxford, UK.

Eric Borgstein (E)

Departments of Pediatrics and Surgery, College of Medicine, University of Malawi, Blantyre, Malawi.

George N Liomba (GN)

Departments of Pediatrics and Surgery, College of Medicine, University of Malawi, Blantyre, Malawi.

Steve Kamiza (S)

Departments of Pediatrics and Surgery, College of Medicine, University of Malawi, Blantyre, Malawi.

Nyengo Mkandawire (N)

Departments of Pediatrics and Surgery, College of Medicine, University of Malawi, Blantyre, Malawi.

Collins Mitambo (C)

Research Department, Ministry of Health, P.O. Box 30377, Lilongwe 3, Malawi.

Elizabeth M Molyneux (EM)

Departments of Pediatrics and Surgery, College of Medicine, University of Malawi, Blantyre, Malawi.

Robert Newton (R)

Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, UK.

Selina Glaser (S)

Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.

Helene Kretzmer (H)

Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany.

Michelle Manning (M)

Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD, USA.
Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.

Amy Hutchinson (A)

Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD, USA.
Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.

Ann W Hsing (AW)

Stanford Cancer Institute, Stanford University, Stanford, Palo Alto, CA, USA.

Yao Tettey (Y)

Department of Pathology, University of Ghana Medical School, College of Health Sciences, P.O. Box KB 52, Korle-Bu, Accra, Ghana.

Andrew A Adjei (AA)

Department of Pathology, University of Ghana Medical School, College of Health Sciences, P.O. Box KB 52, Korle-Bu, Accra, Ghana.

Stephen J Chanock (SJ)

Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD, USA.
Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.

Reiner Siebert (R)

Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.

Meredith Yeager (M)

Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD, USA.
Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.

Ludmila Prokunina-Olsson (L)

Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD, USA.

Mitchell J Machiela (MJ)

Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD, USA.

Sam M Mbulaiteye (SM)

Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD, USA. mbulaits@mail.nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH